Treatment-related damage in elderly-onset ANCA-associated vasculitis: safety outcome analysis of two nationwide prospective cohort studies

BACKGROUND: It is not elucidated that there is treatment-related damage in elderly patients with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). METHODS: Elderly (≥ 75 years of age) patients were enrolled from two nationwide prospective inception cohort studies. The primary o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sada, Ken-Ei, Ohashi, Keiji, Asano, Yosuke, Hayashi, Keigo, Morishita, Michiko, Watanabe, Haruki, Matsumoto, Yoshinori, Fujimoto, Shouichi, Takasaki, Yoshinari, Yamagata, Kunihiro, Banno, Shogo, Dobashi, Hiroaki, Amano, Koichi, Harigai, Masayoshi, Arimura, Yoshihiro, Makino, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552473/
https://www.ncbi.nlm.nih.gov/pubmed/33046139
http://dx.doi.org/10.1186/s13075-020-02341-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552473/
https://www.ncbi.nlm.nih.gov/pubmed/33046139
http://dx.doi.org/10.1186/s13075-020-02341-6

Ejemplares similares